AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Plasma Radiofrequency Ablation at Low Temperature Versus Electrocautery Block Resection at High Frequency for Localized Recurrent Nasopharyngeal Carcinoma

RecruitingNAAges 18 Years - 70 YearsAllSun Yat-sen University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This study aims at exploring whether plasma radiofrequency ablation at low temperature is associated with better survival outcome in localized recurrent nasopharyngeal carcinoma by conducting a randomized controlled trial of plasma radiofrequency ablation at low temperature versus electrocautery block resection at high frequency for localized recurrent nasopharyngeal carcinoma. If the hypothesis is confirmed, it is expected to provide a convenient choice for the surgical treatment of localized recurrent nasopharyngeal carcinoma.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. At least 6 months disease free interval (defined as duration between the initial course of radiotherapy and recurrence) 2. Histopathologically diagnosed with undifferentiated or differentiated, nonkeratinizing nasopharyngeal carcinoma. 3. Resectable recurrent nasopharyngeal carcinoma: rT1-3N0-3M0 A) The tumor is confined to the nasopharyngeal mucosa, or the surface of the parapharyngeal space, or the bottom wall of the sphenoid sinus, and is more than 0.5cm away from the internal carotid artery B) The cervical lymph node lesions do not infiltrate the cervical spine, brachial plexus, cervical muscles, and internal carotid artery. 4. Age: 18-70 years old. 5. Subjects must sign an informed consent form. Exclusion Criteria: 1. Karnofsky score (KPS)โ‰ค70. 2. Has known Subjects with other malignant tumors. 3. Has seriously mental disease. 4. Uncontrolled clinically significant heart disease and Pulmonary dysfunction. 5. Pregnancy or breast feeding.
๐Ÿ’Š

What it tests

  • Plasma radiofrequency ablation
  • Electrocautery block resection
๐Ÿ“

Where

3 sites
Sun Yat-sen University Cancer Center
Guangzhou, China
The Fifth Affiliated Hospital of Sun Yat-sen University
Zhuhai, China
The Nanchang Affiliated Hospital, Sun Yat-Sen University (Nanchang First Hospital)
Nanchang, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy